Table 1.
Case | CD5 | CD23 | CD10 | CD43 | IgD | Histologic Findings |
---|---|---|---|---|---|---|
3 | + (flow) | + | − | NE | + | Diffuse RP involvement by small lymphocytes, atrophic WP (λ-bright, CD20-dim+, FMC7−, CD103, CD11c−, CD25+ by flow cytometry) |
6 | + | − | − | + | + | WP predominantly CD5 positive small cells with attenuated rim of CD5 negative MZ-type cells |
12 | − | − | − | − | − | Diffuse RP involvement by small lymphocytes, atrophic WP |
13 | − | − | − | − | − | Non-MZ-like RP involvement, no WP expansion, light chain restricted plasma cells, lymph node involvement most consistent with MZ lymphoma, also chronic myeloproliferative neoplasm |
15 | − | − | − | NE | − | Micronodular RP infiltrate of small lymphocytes, atrophic WP |
16 | + | + | − | + | + | Morphology like SMZL, phenotype more like CLL (κ-intermediate intensity, CD20-dim, FMC7−, CD38+ by flow cytometry) |
23 | − | − | − | − | + | Mostly MZ-like cells but extensive RP involvement, WP also involved but not expanded |
24 | − | − | − | − | NE | All small lymphs with both WP and RP involvement |
28 | − | − | − | − | − | All small lymphs with both WP and RP involvement |
32 | − | − | − | NE | NE | Lymphoplasmacytic RP nodules with epithelioid histiocyte clusters, no WP involvement, LN consistent with lymphoplasmacytic lymphoma - favor lymphoplasmacytic lymphoma* |
36 | − | − | − | − | + | Plasmacytoid cells with no MZ-like cells but expanded WP |
37 | − | − | − | − | − | All small lymphs with both WP and RP involvement |
38 | − | − | − | + | + | WP with large cells including MZ-like cells, transformed cells, and angulated cells surrounded by a rim of small cells |
40 | − | − | − | NE | + | All small lymphs with both WP and RP involvement |
43 | − | − | − | − | + | Small lymphs with extensive RP involvement but focally prominent WP |
44 | − | − | − | − | − | Small lymphs with extensive RP involvement but focally prominent WP |
NE = Not evaluable, WP= white pulp, RP=red pulp, lymphs=lymphocytes
This patient had an IgM kappa paraprotein, cold agglutinin disease and marrow involvement.